AKT1 and neoplasm: The phosphorylation of RUNX2 by AKT, ERK and p38 and the effect of these phosphorylation events on RUNX2 activity have to be contextualized in tumor cells exhibiting continuous cross-talk between the RAS/MAPK and PI3K/AKT pathways [80].